Cimbi-5
- Molecular formula
- C22H27N3O2
- CAS Number
- 150431-07-5
- IUPAC Name
- 5,6-dimethoxy-2-methyl-3-[2-(4-phenylpiperazin-1-yl)ethyl]-1H-indole
- Molecular Weight
- 369.49g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.2400g/cm3
- Synonyms
- oxypertine
Identification
5,6-Dimethoxy-2-methyl-3-[2-(4-phenylpiperazin-1-yl)ethyl]-1H-indole
This intriguing compound belongs to the indole class of compounds, which are known for their diverse range of biological activities. More specifically, this compound is a derivative of an indole, making it an interesting subject for research in the fields of pharmacology and medicinal chemistry.
Key Features:
- Pharmacological Potential: Compounds of this nature are often investigated for their potential therapeutic effects, including anti-depressant or anti-anxiety properties.
- Structural Complexity: The presence of dimethoxy groups on the indole ring contributes to the compound's unique chemical behavior and interaction with biological targets.
- Mechanism of Action: The incorporation of a piperazine ring in its structure is notable, as this moiety is frequently found in pharmaceuticals that target the central nervous system.
Researchers synthetically produce this compound to explore its effects on neurotransmitter systems, particularly serotonin and dopamine pathways, which are crucial in mood regulation. The phenylpiperazine segment is particularly interesting, as it is known for enhancing selective serotonin reuptake inhibition.
In the words of renowned chemist, “Each compound tells a story uniquely its own; the challenge is to decode its narrative.” This compound certainly has a story worth investigating, highlighting not only the fascinating complexity of its structure but also the limitless potential that indole derivatives offer in modern medicinal chemistry.
Overall, 5,6-dimethoxy-2-methyl-3-[2-(4-phenylpiperazin-1-yl)ethyl]-1H-indole exemplifies the intersection of complexity and utility that is hallmark to chemical research, opening doors for novel therapeutic avenues.